Immunomodulatory natural products via toll-like receptor 2 signalling: from agonists to inhibitors across diverse natural sources

Natural products modulate TLR2 signalling via structurally distinct agonists and inhibitors. Pocket partitioning, chain branching and head-group interactions govern selectivity, while diverse inhibitors converge on TLR2 as a druggable target.